•Tim has almost 30 years of experience in Nonclinical Drug Safety, with expertise focusing on building nonclinical safety assessment strategies for biologic and small molecule therapeutics in order to guide safe first in human use and continued clinical development through registration
•Tim worked for 26 years at Johnson & Johnson (J&J) within their pharmaceutical sector holding various positions with increasing responsibility. Prior to leaving J&J, he was Vice President and Global Head of Nonclinical Drug Safety for Janssen R&D. He has had responsibility for the development of many biologic and small molecule therapeutics, a number of which ultimately achieved global registration and approval. Additionally, as an expert in the area of nonclinical support for therapeutics to be used in pediatric populations. He has given numerous presentations, and written several articles and book chapters on this topic
•Tim earned a Ph.D. in Pharmacology from the University of the Sciences (formerly The Philadelphia College of Pharmacy & Science) and is Board Certified in Toxicology. He is a full member of the Society of Toxicology, a Past-President of the Mid-Atlantic Chapter of the Society of Toxicology and was an Adjunct Assistant Professor in the School of Pharmacy at Temple University
